Between 2022 to 2027, the hemodialysis market in Europe is expected to grow at a CAGR of 4.49%, and the market size is predicted to be worth USD 34.89 billion by 2027 from USD 28.01 billion in 2022.
The growing incidence of kidney-related diseases is driving the growth of the European hemodialysis market. In Europe, an estimated 100 million people suffer from kidney-related disorders. Kidney-related diseases may occur due to several reasons, such as complications at the time of birth, genetic issues, increasing consumption of alcohol, an unhealthy diet, etc. Furthermore, increasing mortality rates due to kidney diseases encourage people to opt for hemodialysis treatment based on the severity of their condition to support their lifespan and achieve a quality life. Furthermore, an increase in hypertension and heart-related disorder is also the reason for kidney failure disorders in many people.
The scarcity of kidney donors across the European region for transplantation is another major factor fuelling the market’s growth rate. Patients waiting for kidney transplantation go through hemodialysis for proper kidney functioning until they get kidney transplantation. In addition, the growing adoption of technological advancements and the launch of new products for dialysis procedures are contributing to the rise of the hemodialysis market in Europe. Furthermore, the growing R&D activities around artificial kidneys to offer them at affordable prices by the key market participants in the European region are supporting the growth rate of the European market.
Furthermore, most researchers also focus on developing various types of advanced hemodialysis devices to simplify the hemodialysis process further and increase production for home-based hemodialysis equipment to boost the regional market growth. The adoption of home dialysis is growing rapidly in Europe and is expected to boost the European hemodialysis market growth. Aged and people who are disabled prefer to have home dialysis these days to avoid traveling. In-home dialysis, skilled professionals would handle the procedures, so it is a safe option.
However, complications associated with the hemodialysis procedures, such as low blood pressure, nausea, and anemia, hampering European market growth. Due to these complications with dialysis procedures, the adoption is less among kidney failure patients. In addition, the high costs associated with hemodialysis procedures limit the market’s growth rate in Europe. Furthermore, the lack of reimbursement policies, skilled professionals, and proper hospital infrastructure impedes the market growth.
This research report on the Europe hemodialysis market has been segmented and sub-segmented into the following categories.
By Products And Services:
Geographically, the European region accounted for the largest share of the worldwide market in 2021 and is anticipated to hold a a considerable share during the forecast period owing to the increasing aging population and healthcare expenditure. In addition, clinical trials for chronic kidney diseases have increased due to increasing investment by the government and the prominent key players in the region. The growing number of clinical trials helps give the best treatment to a patient suffering from kidney disease through hemodialysis treatment. In addition, the increasing diabetic population in this region also helps the growth of the market. The population suffering from diabetics and end-stage renal disease may prefer hemodialysis for up to 15 months.
Germany is a potential market in the European region for hemodialysis. An increasing number of clinical centers for hemodialysis treatment is the primary factor for the market growth in Germany. In addition, a recent survey by the German Kidney Center shows nearly 50,000 people have severe kidney illness, which requires lifelong blood purification that can only be done by dialysis.
The UK is estimated to showcase a healthy CAGR during the forecast period. An increasing number of awareness programs about hemodialysis by the government and healthcare organizations in the United Kingdom are the main factors for market growth. A survey in England shows nearly 58,000 people receive renal replacement therapy annually. Among them, four people are taking the blood cleaning process through hemodialysis. In addition, in the United Kingdom, free service is given to people who need dialysis through the Kidney Care UK Dialysis Freedom service.
KEY MARKET PLAYERS:
Nikkiso Co., Ltd, Nipro Corporation, NxStage Medical, Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc, Cantel Medical Corp, DaVita Inc, Diaverum and Fresenius Medical Care AG & Co. KGaA are some of the notable companies in the European hemodialysis market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]